Table 3 Relationships between clinicopathological characteristics of PTC patients and BRAF^V600E mutation status and BANCR and miR-9 expression in carcinoma tissue (n = 51)

Sex

0.471

0.742

0.475

 Female

27

10

26

11

20

17

 Male

12

2

9

5

6

8

Age (years)

0.497

0.221

0.180

 ≤ 45

23

9

20

12

14

18

 > 45

16

3

15

4

12

7

Tumor location

< 0.001

0.654

0.645

 Unilateral

9

11

13

7

11

9

 Bilateral

30

1

22

9

15

16

Tumor size (cm/mean)

1.8 ± 0.7

1.3 ± 0.4

0.002

1.7 ± 0.8

1.5 ± 0.6

0.501

1.6 ± 0.8

1.7 ± 0.7

0.756

Multifocality

0.003

0.510

0.104

 Single

7

8

9

6

5

10

 Multiple (≥ 2)

32

4

26

10

21

15

Extracapsular invasion

0.004

0.036

0.121

 No

14

10

13

11

15

9

 Yes

25

2

22

5

11

16

Extrathyroid extension

0.173

0.694

0.140

 No

31

12

30

13

24

19

 Yes

8

0

5

3

2

6

Hashimoto’s disease

0.616

0.363

0.419

 No

35

10

32

13

24

21

 Yes

4

2

3

3

2

4

Central LNM

0.101

0.202

0.012

 No

12

7

12

6

14

5

 Yes

27

5

23

10

12

20

Lateral LNM

0.042

0.033

0.029

 No

23

11

20

14

21

13

 Yes

16

1

15

2

5

12

TNM stage

0.110

0.470

0.291

 T1

17

9

16

10

15

11

 T2

14

3

12

5

9

8

 T3

8

0

7

1

2

6